CARYSIL.NS(CARYSIL.NS)
CARYSIL.NS
No analyst ratings available
No analyst price targets available for CARYSIL.NS
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E |
|---|---|---|
| Revenue Avg | $10.81B | $12.66B |
| Low | $10.77B | $12.57B |
| High | $10.86B | $12.77B |
| EBITDA Avg | $2.11B | $2.47B |
| Low | $2.10B | $2.45B |
| High | $2.12B | $2.49B |
| EBIT Avg | $1.64B | $1.92B |
| Low | $1.64B | $1.91B |
| High | $1.65B | $1.94B |
| Net Income Avg | $1.16B | $1.44B |
| Low | $1.10B | $1.41B |
| High | $1.19B | $1.46B |
| EPS Avg | $40.67 | $50.48 |
| Low | $38.75 | $49.69 |
| High | $41.84 | $51.33 |
| Analysts (Rev / EPS) | 1 / 3 | 3 / 3 |